DCTH Stock Chart

Delcath Systems is an interventional oncology company which focuses on the treatment of primary and metastatic liver cancers. The Company is developing melphalan hydrochloride for Injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver.